SGP
HEALTHCARESpyGlass Pharma Inc
Live · NASDAQ · May 9, Close
What's Moving SGP Today?
No stock-specific AI insight has been generated for SGP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$25.06
Fundamentals
Trading
SGP News
8 articles- SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate UpdateYahoo Finance·Mar 26, 2026
- SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL SystemYahoo Finance·Mar 9, 2026
- SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach SummitYahoo Finance·Mar 4, 2026
- MongoDB downgraded, Block upgraded: Wall Street's top analyst callsYahoo Finance·Mar 3, 2026
- SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesYahoo Finance·Feb 9, 2026
- Sector Update: Health Care Stocks Rise Late AfternoonYahoo Finance·Feb 6, 2026
- Sector Update: Health Care Stocks Rise in Afternoon TradingYahoo Finance·Feb 6, 2026
- SpyGlass Pharma Announces Pricing of Initial Public OfferingYahoo Finance·Feb 6, 2026
All 8 articles loaded
Price Data
52-Week Range
$25.06
Fundamentals
Trading
About SpyGlass Pharma Inc
SpyGlass Pharma, Inc. (SGP) is at the forefront of biopharmaceutical innovation, dedicated to the development and commercialization of groundbreaking therapies targeting critical health conditions. With a diverse and promising pipeline, SGP is committed to leveraging cutting-edge technologies to fulfill unmet medical needs and improve patient outcomes. The company's strategic alliances enhance its competitive edge and support its growth strategies, positioning SGP as an attractive investment opportunity for institutional investors interested in the dynamic biopharmaceutical sector.